Question 1

Has Manmohan Singh received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $408,479 in general payments to Manmohan Singh across 804 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Manmohan Singh did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Manmohan Singh come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Alkermes, Inc.	300	$198,081
AbbVie(2 entities)	399	$166,322
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	53	$39,684
Axsome Therapeutics, Inc.	5	$2,932
Teva Pharmaceuticals USA, Inc.	24	$326
Otsuka America Pharmaceutical, Inc.	10	$254
E.r. Squibb & Sons, L.L.C.	2	$244
Johnson & Johnson	3	$204
MDD US Operations, LLC	1	$119
Ironshore Pharmaceuticals Inc.	1	$98
Jazz Pharmaceuticals Inc.	1	$62
Idorsia Pharmaceuticals US Inc	1	$57
Lundbeck LLC	2	$35
Corium, LLC	1	$32
Vanda Pharmaceuticals Inc.	1	$29

Manmohan Singh

Payments from drug & device makers

Who reported the general payments

How this compares

Other psychiatry in Des Moines